Early cycling-independent changes to p27, cyclin D2, and cyclin D3 in differentiating mouse embryonal carcinoma cells

Cell Growth and Differentiation

Volumn 13, Issue 9, 2002, Pages 421-430

  Preclíková, Helena ^a   Bryja, Vitězslav ^a   Pacherník, Jiří ^a   Krejčí, Pavel ^a   Dvořák, Petr ^a   Hampl, Aleš ^a  

^a MENDEL UNIVERSITY IN BRNO   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D2; CYCLIN D3; PROTEIN P27;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CARCINOMA CELL; CELL CYCLE; CELL DIFFERENTIATION; EMBRYO DEVELOPMENT; GROWTH RATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANIMALS; CARCINOMA, EMBRYONAL; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOHISTOCHEMISTRY; MICE; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

ANIMALIA;

EID: 0036741734     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D., and Lassar, A. B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (Wash. DC), 267: 1018-1021, 1995.
2. Liu, Q., VanHoy, R. W., Zhou, J. H., Dantzer, R., Freund, G. G., and Kelley, K. W. Elevated cyclin E levels, inactive retinoblastoma protein, and suppression of the p27KIP1 inhibitor characterize early development of promyeloid cells into macrophages. Mol. Cell. Biol., 19: 6229-6239, 1999.
3. Evans, M. J., and Kaufman, M. H. Establishment in culture of pluripotential cells from mouse embryos. Nature (Lond.), 292: 154-156, 1981.
4. Martin, G. R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA, 78: 7634-7636, 1981.
5. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., and Jones, J. M. Embryonic stem cell lines derived from human blastocysts. Science (Wash. DC), 282: 1145-1147, 1998.
6. Martin, G. R. Teratocarcinoma and mammalian embryogenesis. Science (Wash. DC), 209: 768-776, 1980.
7. Odorico, J. S., Kaufman, D. S., and Thomson, J. A. Multilineage differentiation from human embryonic stem cell lines. Stem Cells, 19: 193-204, 2001.
8. Rohwedel, J., Guan, K., and Wobus, A. M. Induction of cellular differentiation by retinoic acid in vitro. Cells Tissues Organs, 165: 190-202, 1999.
9. Edwards, M. K., and McBurney, M. W. The concentration of retinoic acid determines the differentiated cell types formed by a teratocarcinoma cell line. Dev. Biol., 98: 187-191, 1983.
10. Savatier, P., Lapillonne, H., van Grunsven, L. A., Rudkin, B. B., and Samarut, J. Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells. Oncogene, 12: 309-322, 1995.
11. Sasaki, K., Tamura, S., Tachibana, H., Sugita, M., Gao, Y., Furuyama, J., Kakishita, E., Sakai, T., Tamaoki, T., and Hashimoto-Tamaoki, T. Expression and role of p27kip1 in neuronal differentiation of embryonal carcinoma cells. Mol. Brain Res., 77: 209-221, 2000.
12. Kranenburg, O., de Groot, R. P., Van der Eb, A., and Zantema, A. Differentiation of P19 EC cells leads to differential modulation of cyclin-dependent kinase activities and to changes in the cell cycle profile. Oncogene, 10: 87-95, 1995.
13. Watanabe, Y., Watanabe, T., Kitagawa, M., Taya, Y., Nakayama, K., and Motoyama, N. pRb phosphorylation is regulated differentially by cyclin-dependent kinase (Cdk) 2 and Cdk4 in retinoic acid-induced neuronal differentiation of P19 cells. Brain Res., 842: 342-350, 1999.
14. Gill, R. M., Slack, R., Kiess, M., and Hamel, P. A. Regulation of expression and activity of distinct pRB. E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells. Exp. Cell Res., 244: 157-170, 1998.
15. Baldassarre, G., Barone, M. V., Belletti, B., Sandomenico, C., Bruni, P., Spiezia, S., Boccia, A., Vento, M. T., Romano, A., Pepe, S., Fusco, A., and Viglietto, G. Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cells survival and differentiation. Oncogene, 18: 6241-6251, 1999.
16. Durand, B., Gao, F. B., and Raff, M. Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J., 16: 306-317, 1997.
17. Burton, P. B., Raff, M. C., Kerr, P., Yacoub, M. H., and Barton, P. J. An intrinsic timer that controls cell-cycle withdrawal in cultured cardiac myocytes. Dev. Biol., 216: 659-670, 1999.
18. Hauser, P. J., Agrawal, D., Flanagan, M., and Pledger, W. J. The role of p27Kip1 in the in vitro differentiation of murine keratinocytes. Cell Growth Differ., 8: 203-211, 1997.
19. Hampl, A., Pachernik, J., and Dvorak, P. Levels and interactions of p27, cyclin D3, and CDK4 during the formation and maintenance of the corpus luteum in mice. Biol. Reprod., 62: 1393-1401, 2000.
20. Draber, P., and Maly, P. Mutants of embryonal carcinoma cells defective in the expression of embryoglycan. Proc. Natl. Acad. Sci. USA, 84: 5798-5802, 1987.
21. Bain, G., Ray, W. J., Yao, M., and Gottlieb, D. I. Retinoic acid promotes neural and represses mesodermal gene expression in mouse embryonic stem cells in culture. Biochem. Biophys. Res. Commun., 223: 691-694, 1996.
22. Gajovic, S., St-Onge, L., Yokota, Y., and Gruss, P. Retinoic acid mediates Pax6 expression during in vitro differentiation of embryonic stem cells. Differentiation (Camb.), 62: 187-192, 1997.
23. Baldassarre, G., Boccia, A., Bruni, P., Sandomenico, C., Barone, M. V., Pepe, S., Angrisano, T., Belletti, B., Motti, M. L., Fusco, A., and Viglietto, G. Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27. Cell Growth Differ., 11: 517-526, 2000.
24. Faria, T. N., LaRosa, G. J., Wilen, E., Liao, J., and Gudas, L. J. Characterization of genes which exhibit reduced expression during the retinoic acid-induced differentiation of F9 teratocarcinoma cells: involvement of cyclin D3 in RA-mediated growth arrest. Mol. Cell. Endocrinol., 143: 155-166, 1998.
25. Reynisdottir, L, Polyak, K., Iavarone, A., and Massagué, J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev., 9: 1831-1845, 1995.
26. Blain, S. W., Montalvo, E., and Massagué, J. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J. Biol. Chem., 272: 25863-25872, 1997.
27. Doki, Y., Imoto, M., Han, E. K., Sgambato, A., and Weinstein, I. B. Increased expression of the p27KIP1 protein in human esophageal cancer cell lines that overexpress cyclin D1. Carcinogenesis (Lond.), 18: 1139-1148, 1997.
28. Yamamoto, H., Soh, J. W., Shirin, H., Xing, W. Q., Lim, J. T., Yao, Y., Slosberg, E., Tomita, N., Schieren, I., and Weinstein, I. B. Comparative effects of overexpression of p27Kip1 and p21Cip1/Waf1 on growth and differentiation in human colon carcinoma cells. Oncogene, 18: 103-115, 1999.
29. Bagui, T. K., Jackson, R. J., Agrawal, D., and Pledger, W. J. Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27Kip1 and p21cip1. Mol. Cell. Biol., 20: 8748-8757, 2000.
30. Barnouin, K., Fredersdorf, S., Eddaoudi, A., Mittnacht, S., Pan, L. X., Du, M. Q., and Lu, X. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells. Oncogene, 18: 6388-6397, 1999.
31. Fredersdorf, S., Burns, J., Milne, A. M., Packham, G., Fallis, L., Gillett, C. E., Royds, J. A., Peston, D., Hall, P. A., Hanby, A. M., Barnes, D. M., Shousha, S., O'Hare, M. J., and Lu, X. High level expression of p27kip1 and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27kip1 and degree of malignancy in human breast and colorectal cancers. Proc. Natl. Acad. Sci. USA, 94: 6380-6385, 1997.
32. Sanchez-Beato, M., Camacho, F. I., Martinez-Montero, J. C., Saez, A. I., Villuendas, R., Sanchez-Verde, L., Garcia, J. F., and Piris, M. A. Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. P27/KIP1-cyclin D3 colocalization in tumor cells. Blood, 94: 765-772, 1999.
33. Baldassarre, G., Belletti, B., Bruni, P., Boccia, A., Trapasso, F., Pentimalli, F., Barone, M. V., Chiappetta, G., Vento, M. T., Spiezia, S., Fusco, A., and Viglietto, G. Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells. J. Clin. Investig., 104: 865-874, 1999.
34. Zimmet, J. M., Ladd, D., Jackson, C. W., Stenberg, P. E., and Ravid, K. A role for cyclin D3 in the endomitotic cell cycle. Mol. Cell. Biol., 17: 7248-7259, 1997.
35. Bernards, R. CDK-independent activities of D type cyclins. Biochim. Biophys. Acta, 1424: M17-M22, 1999.
36. Ohnuma, S., Philpot, A., Wang, K., Holt, C. E., and Harris, W. A. p27Xic1, a Cdk inhibitor, promotes the determination of glial cells in Xenopus retina. Cell, 99: 499-510, 1999.
37. Kiess, M., Gill, R. M., and Hamel, P. A. Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogene, 10: 159-166, 1995.
38. Kolluri, S. K., Weiss, C., Koff, A., and Gottlicher, M. p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev., 13: 1742-1753, 1999.
39. Rosenwald, I. B., Kaspar, R., Rousseau, D., Gehrke, L., Leboulch, P., Chen, J. J., Schmidt, E. V., Sonenberg, N., and London, I. M. Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels. J. Biol. Chem., 270: 21176-21180, 1995.
40. Garcia-Gras, A. E., Chi, P., and Thompson, A. E. Glucocorticoid-mediated destabilization of cyclin D3 mRNA involves RNA-protein interactions in the 3′-untranslated region of the mRNA. J. Biol. Chem., 275: 22001-22008, 2000.
41. 2-phase lengthening mediated by glucocorticoids in normal human lymphocytes. Cell Growth Differ., 10: 405-412, 1999.
42. Millard, S. S., Yan, J. S., Nguyen, H., Pagano, M., Kiyokawa, H., and Koff, A. Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest. J. Biol. Chem., 272: 7093-7098, 1997.
43. Millard, S. S., Vidal, A., Markus, M., and Koff, A. A U-rich element in the 5′ untranslated region is necessary for the translation of p27 mRNA. Mol. Cell. Biol., 20: 5947-5959, 2000.
44. Hengst, L., and Reed, S. Translational control of p27Kip1 accumulation during the cell cycle. Science (Wash. DC), 271: 1861-1864, 1996.
45. Welcker, M., Lukas, J., Strauss, M., and Bartek, J. Enhanced protein stability: a novel mechanism of D-type cyclin over-abundance identified in human sarcoma cells. Oncogene, 13: 419-425, 1996.
46. Nguyen, H., Gitig, D. M., and Koff, A. Cell-free degradation of p27Kip1, a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome. Mol. Cell. Biol., 19: 1190-1201, 1999.
47. Pagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P. R., Draetta, G. F., and Rolfe, M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (Wash. DC), 269: 682-685, 1995.
48. Vindelov, L. L. Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. Virchows Arch. B Cell. Pathol., 24: 227-242, 1977.
49. Chen, C. and Okayama, H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell Biol., 8: 2745-2752, 1987.